Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?
Saved in:
| Title: | Experimental drugs for erosive esophagitis: what is in the clinical development pipeline? |
|---|---|
| Authors: | Simadibrata DM; Department of Medicine, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.; Medicine, Universitas Indonesia, Jakarta, Indonesia.; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Lesmana E; Medicine, Universitas Indonesia, Jakarta, Indonesia.; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Lee YY; School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia.; GI Function and Motility Unit, Hospital USM, Kota Bharu, Malaysia. |
| Source: | Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2024 Oct; Vol. 33 (10), pp. 1009-1018. Date of Electronic Publication: 2024 Aug 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
